To improve patient diagnosis and therapy, there is a need to advance patient-specific dosimetry, said Hal Anger Lectureship & Award lecturer Michael G. Stabin, a researcher at Vanderbilt University School of Medicine, in a message at the SNMMI Annual Meeting. "We have a new generation of dose phantoms and selection of sophisticated [dose planning tools and] methods ... and it's time to incorporate dose calculations into clinical therapy planning ... Our understanding of radiobiology is undergoing profound change. We will be rewriting history soon," Stabin said.

Related Summaries